글로버메뉴 바로가기 본문 바로가기 하단메뉴 바로가기

논문검색은 역시 페이퍼서치

Pediatric Infection and Vaccine검색

Pediatr Infect Vaccine


  • - 주제 : 의약학분야 > 소아과학
  • - 성격 : 학술지
  • - 간기: 연3회
  • - 국내 등재 : KCI 등재
  • - 해외 등재 : - / SCOPUS
  • - ISSN : 2384-1079
  • - 간행물명 변경 사항 : 소아감염 → pediatric infection and vaccine
논문제목
수록 범위 : 3권 1호 (1996)

Haemophilus influenzae b형(Hib) 예방접종

이환종
4,500
키워드보기
초록보기

폐구균 감염의 예방접종

차성호
4,500
키워드보기
초록보기

Jennerian reassortment rotavirus vaccines

김경희 ( Kyung Hee Kim )
4,500
키워드보기
초록보기
Rotavirus (Rv) is the most common cause of severe dehydrating diarrhea in infants and young children worldwide, infecting nearly every child in the first few years of life, and thus justifying universal childhood immunization when a safe and effective vaccine is available. In Korea, Rv is the most prevalent enteropathogen identified in the stools of children with diarrhea, accounting for 46 to 68% of cases. Rv contains 11 segments of double-stranded RNA, each coding for a viral protein, inside a 70-nm triple layered protein capsid. Of particular interest for vaccine development are the two outer capsid proteins, VP7 and VP4, that are involved in viral virulence, host range restriction, hemagglutination, serotype specificity, neutralization, disease prevention, and cell attachment and penetration. The two neutralization proteins form the basis for the current classfication of group A Rv into G (VP7) and P (VP4) serotypes. To date at least 9 human G serotypes and 6 human P serotypes have been found, with G1 through G4, P4 and P8 being the most prevalent. For most countries surveyed, including Korea, four main types are G1P8, G2P4, G3P8, and G4P8. In India, however, P6 (G1P6, G2P6, G3P6, G4P6, andG9P6) that primarily infect asymptomatic newborns but are rare in diarrheal children were common with G9P6, a strain not previously reported in diarrheal children, the most prevalent. Rv crosses species barriers. The rhesus monkey Rv strain MMU18006 (RRV, G3) was found to be immunogenic and mildly reactogenic human trials. The RPV vaccine was protective against homotypic G3 illness, but efficacy against heterotypic Rv strains was variable. Since Rv has a segmented genome, one approach that has been taken to induce protection against human serotypes is to use a monovalent vaccine (RRV-G1) containing a human Rv with G1 VP7 and 10 RRV genes because G1 infections are the most common. Another approach is to use the tetravalent vaccine (RRV-TV) containing 4 viruses including one each in which the VP7 for human G1, 2, or 4 replaced the RRV VP7, as well as RRV itself, which has a VP7 corresponding to G3. In randomized, double-blind trials in the US, both live oral RRV-G1 and RRV-TV, reduced the incidence of Rv gastroenteritis (P<0.001). Vaccine efficacy against disease caused by G1 infection, the most common type detected in the US (71%), was 44% for RRV-TV and 55% for RRV-S1. RRV-TV and RRV-S1 prevented 77% and 45%, respectively, of disease caused by G3, the second most common type (19%) in the US at the time of the study. Current Jennerian reassortant vaccines that contain only VP7 antigens from human strains could be improved by addition of a VP4 gene from a human strain as a separate reassortant.

A형 간염 백신

손영모
4,500
키워드보기
초록보기

New and improved recombinant hepatitis B vaccine

( Jae-wook Huh )
1,000
키워드보기
초록보기

Approach to a vaccine against Pseudomonas aeruginosa

김현수
1,000
키워드보기
초록보기

Future use of varicella vaccine

( Jeong-min Kim )
1,000
키워드보기
초록보기

New and improved influenza vaccine

( Baik L. Seong )
1,000
키워드보기
초록보기

과립 백혈구 감소증 환자에서의 항생제 사용

김광남
1,000
키워드보기
초록보기

간질환 환아에서의 항생제 사용

김미란
5,400
키워드보기
초록보기
1 2 >